Split Rock Partners

Split Rock Partners, LLC is a venture capital firm established in June 2004, focused on early-stage investments in emerging healthcare, software, and internet services companies, primarily in the Upper Midwest and West Coast regions of the United States. The firm employs flexible investment strategies, including primary investments and direct secondaries, targeting companies with a market size exceeding $500 million. Split Rock Partners typically invests between $8 million to $10 million, seeking opportunities in sectors such as therapeutic medical devices, web-based business services, marketing automation, and enterprise analytics. The firm aims for its portfolio companies to achieve significant growth, generating over $100 million in revenue within five years and reaching a valuation of over $1 billion. Split Rock Partners emphasizes collaboration with entrepreneurs, leveraging over 80 years of combined venture investing and management experience to build strong partnerships based on integrity and mutual respect.

Josh Baltzell

VP

Michael Gorman

Managing Director

Steven Schwen

CFO

James Simons

Managing Director

Jim Simons

Managing Director

David (Dave) Stassen

Managing Director

102 past transactions

Gravia

Series E in 2022
Gravie, Inc. operates a health insurance platform that facilitates the comparison and purchase of health insurance plans for individuals, families, and employers. Founded in 2013 and headquartered in Minneapolis, Minnesota, the company provides a comprehensive solution for managing health insurance expenses through its mobile application and website. Gravie allows users to shop for insurance options available on government-run exchanges and directly from insurance companies. The platform also offers tools for employers to design custom benefits plans using a defined contribution approach, enabling them to set a fixed budget for employee health benefits. Additionally, Gravie provides year-round support, financial analysis, and services such as Gravie Care, which assists individuals in managing their healthcare expenses effectively.

Gravia

Series D in 2021
Gravie, Inc. operates a health insurance platform that facilitates the comparison and purchase of health insurance plans for individuals, families, and employers. Founded in 2013 and headquartered in Minneapolis, Minnesota, the company provides a comprehensive solution for managing health insurance expenses through its mobile application and website. Gravie allows users to shop for insurance options available on government-run exchanges and directly from insurance companies. The platform also offers tools for employers to design custom benefits plans using a defined contribution approach, enabling them to set a fixed budget for employee health benefits. Additionally, Gravie provides year-round support, financial analysis, and services such as Gravie Care, which assists individuals in managing their healthcare expenses effectively.

EBR Systems

Venture Round in 2019
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Nuvaira

Series E in 2019
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

EBR Systems

Venture Round in 2017
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

TruSignal

Series A in 2017
TruSignal, LLC offers digital marketing services. It provides display, video, and media campaigns on publisher sites, portals, advertisement networks, trading desks, DSPs, advertisement exchanges, and mobile networks. The company is based in St. Cloud, Minnesota. TruSignal, LLC operates as a subsidiary of xTech Holdings, Inc. As of May 22, 2019, TruSignal, Inc. operates as a subsidiary of TransUnion.

Gravia

Series C in 2017
Gravie, Inc. operates a health insurance platform that facilitates the comparison and purchase of health insurance plans for individuals, families, and employers. Founded in 2013 and headquartered in Minneapolis, Minnesota, the company provides a comprehensive solution for managing health insurance expenses through its mobile application and website. Gravie allows users to shop for insurance options available on government-run exchanges and directly from insurance companies. The platform also offers tools for employers to design custom benefits plans using a defined contribution approach, enabling them to set a fixed budget for employee health benefits. Additionally, Gravie provides year-round support, financial analysis, and services such as Gravie Care, which assists individuals in managing their healthcare expenses effectively.

Demandbase

Series H in 2017
Demandbase, Inc. provides comprehensive B2B marketing solutions, specializing in account-based marketing (ABM). Founded in 2005 and based in San Francisco, the company offers a cloud-based platform that enables marketers to enhance their existing technology for more effective ad targeting and web personalization. Demandbase's ABM Platform allows B2B marketers to create and manage targeted campaigns, while its Real-Time Intent technology uses artificial intelligence to identify account interests during the early stages of online research, triggering timely sales and marketing actions. In addition, the company offers solutions for account-based advertising, retargeting, performance management, and web analytics, which collectively provide marketers with insights into site traffic and conversion metrics. Demandbase has established itself as a critical component of the B2B tech ecosystem, helping businesses identify and engage the accounts that are most significant to their growth.

Sparkcentral

Venture Round in 2016
Sparkcentral Inc. provides Sparkcentral, an enterprise social media helpdesk platform for high-volume and real-time engagement. Its platform provides automated workflow, collision control, internal collaboration, customer-centric interface, quicker answers, personalized communication, engagement metrics, team performance, and trend identification. Sparkcentral Inc. has strategic partnerships with Genesys and Calabrio. The company was formerly known as TwitSpark Inc. Sparkcentral Inc. was incorporated in 2012 and is based in San Francisco, California.

Janrain

Series D in 2015
Janrain, Inc. specializes in customer identity and access management (CIAM) solutions, offering the Janrain Identity Cloud, which is designed for real-time identity management, security, and activation for global enterprises. Founded in 2002 and headquartered in Portland, Oregon, Janrain has expanded its presence with additional offices in cities including Redwood City, Austin, London, Paris, Kyiv, Guadalajara, São Paulo, Ningbo, and Bengaluru. The company serves a diverse range of sectors, including consumer brands, financial services, healthcare, and education, among others. Janrain is noted for its pioneering role in developing social login and for being a founding member of the OpenID Foundation, contributing significantly to digital authentication protocols used worldwide. As of early 2019, Janrain operates as a subsidiary of Akamai Technologies, Inc.

Code42

Series B in 2015
Code42 Software, Inc. is an enterprise SaaS provider specializing in cloud endpoint data protection and security solutions for businesses and educational institutions. The company offers several key products, including Code42 CrashPlan, which provides continuous backup of distributed end-user data, and Code42 Next-Gen DLP, a data loss protection solution designed for resource-constrained security and IT teams. Additionally, Code42's Incydr solution safeguards intellectual property, source code, and trade secrets while enabling compliance with regulatory requirements. Founded in 2001 and headquartered in Minneapolis, Minnesota, Code42 has built a reputation for helping over 50,000 organizations globally protect their data without compromising collaboration among employees. The company also has a strategic partnership with Exabeam and maintains a presence in Amersham, United Kingdom.

Acquia

Series G in 2015
Acquia Inc. is a provider of a cloud-based platform designed to create, deliver, and optimize digital experiences for various industries, including government, education, and finance. Founded in 2007 and based in Boston, Massachusetts, Acquia offers a range of solutions such as Acquia Cloud, which supports the development and maintenance of Drupal websites, and Acquia Cloud Site Factory, which allows for the deployment of multiple sites. Their offerings also include Acquia Lift for creating tailored brand sites, Acquia Content Hub for content distribution, and Acquia Journey for data-driven customer engagement. Additionally, Acquia provides tools like Developer Studio for enhancing developer productivity and Acquia Digital Asset Manager for centralizing creative assets. The company's services aim to empower organizations to achieve impactful, contextually relevant digital experiences that enhance customer engagement.

InsideView

Private Equity Round in 2015
InsideView Technologies, Inc. specializes in developing Customer Relationship Management (CRM) solutions that enhance sales, marketing, and account management efforts. Founded in 2005 and based in San Francisco, the company provides a range of products designed to deliver comprehensive company and contact data, social insights, and business connections. Key offerings include InsideView Refresh, which focuses on data cleansing and management for Salesforce users; InsideView Data Integrity for customer data management; and InsideView Append, a lightning data application. The company's Targeting Intelligence platform enables sales and marketing teams to identify and engage with the best prospects, facilitating more relevant interactions and improved deal closures. InsideView's solutions are utilized by over 500,000 professionals across more than 20,000 leading companies, and it maintains partnerships with several major CRM providers, including Microsoft and Salesforce. Additionally, InsideView collaborates with various content providers to enhance its data offerings.

Gravia

Series B in 2015
Gravie, Inc. operates a health insurance platform that facilitates the comparison and purchase of health insurance plans for individuals, families, and employers. Founded in 2013 and headquartered in Minneapolis, Minnesota, the company provides a comprehensive solution for managing health insurance expenses through its mobile application and website. Gravie allows users to shop for insurance options available on government-run exchanges and directly from insurance companies. The platform also offers tools for employers to design custom benefits plans using a defined contribution approach, enabling them to set a fixed budget for employee health benefits. Additionally, Gravie provides year-round support, financial analysis, and services such as Gravie Care, which assists individuals in managing their healthcare expenses effectively.

EBR Systems

Venture Round in 2015
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Sparkcentral

Series B in 2015
Sparkcentral Inc. provides Sparkcentral, an enterprise social media helpdesk platform for high-volume and real-time engagement. Its platform provides automated workflow, collision control, internal collaboration, customer-centric interface, quicker answers, personalized communication, engagement metrics, team performance, and trend identification. Sparkcentral Inc. has strategic partnerships with Genesys and Calabrio. The company was formerly known as TwitSpark Inc. Sparkcentral Inc. was incorporated in 2012 and is based in San Francisco, California.

Histogenics

Post in 2014
Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Our regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Our first investigational product candidate, NeoCart®, leverages our platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.

VoloMetrix

Series B in 2014
VoloMetrix is a people analytics technology company that uses big data to optimize organizational performance, providing executives visibility into the daily activities and relationships that propel business forward. The company's technology helps improve companies’ organizational alignment, drive sales, and promote employee engagement. Working with Fortune 100 companies, VoloMetrix extracts and analyzes anonymous aggregated collaboration data to reveal unprecedented insights into how employee behaviors drive business outcomes.

Zyga Technology

Series D in 2014
Zyga Technology is a surgical solutions provider developing & commercializing medical devices for treating spine problems. In addition to the SImmetry Sacroiliac Joint Fusion System, the company is also developing the Glyder Facet Restoration Device. Zyga has put together a team of engineers, marketing personnel, and management with significant experience developing medical devices for the spine industry. Zyga Technology was founded in 2008 and is headquartered in Minnesota, USA.

Ivantis

Series B in 2014
Ivantis Inc. is dedicated to developing innovative treatments for primary open angle glaucoma, a condition affecting over 60 million people globally. The company has created an intracanalicular scaffold or implantable device designed to alleviate high intraocular pressure in patients, offering a less invasive and more effective therapeutic option. Founded in 2007 and based in Irvine, California, Ivantis also provides a Session Persistence Server, which safeguards telnet task workers against data loss due to network issues and ensures terminal emulation users maintain productivity across various devices and operating systems. As Ivantis advances its glaucoma treatment solutions, it aims to expand its focus to other debilitating ophthalmic diseases. The company primarily serves ophthalmology specialists in the United States, providing its solutions for use in clinical trials.

Colorescience

Series B in 2014
Colorescience, Inc. specializes in the production and sale of mineral-based cosmetics and sunscreen products. Founded in 2000 and based in Carlsbad, California, the company offers a range of treatment products aimed at addressing various skin concerns, including pigmentation, redness, dark circles, and signs of aging, as well as catering to different skin types such as sensitive, oily, and dry skin. Its product line includes UV protectors, primers, foundations, and enhancers, all designed with high-quality ingredients and formulations. Colorescience distinguishes itself in the luxury aesthetic makeup market by focusing on efficacy and ease of use. The company distributes its products through a network of licensed physicians, luxury spas, retailers, and online channels, emphasizing its commitment to reducing skin cancer and other skin conditions.

BlackDuck

Series F in 2014
Black Duck secures and manages open source software worldwide, eliminating open source security vulnerabilities and license compliance pain. With the rapid, widespread adoption of open-source software, Black Duck is a key component of Synopsys’ Software Integrity Platform, the most comprehensive solution for integrating security into the SDLC and software supply chain. Black Duck was established in 2002 and is based in Burlington, Massachusetts, United States.

EBR Systems

Venture Round in 2014
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Acquia

Series F in 2014
Acquia Inc. is a provider of a cloud-based platform designed to create, deliver, and optimize digital experiences for various industries, including government, education, and finance. Founded in 2007 and based in Boston, Massachusetts, Acquia offers a range of solutions such as Acquia Cloud, which supports the development and maintenance of Drupal websites, and Acquia Cloud Site Factory, which allows for the deployment of multiple sites. Their offerings also include Acquia Lift for creating tailored brand sites, Acquia Content Hub for content distribution, and Acquia Journey for data-driven customer engagement. Additionally, Acquia provides tools like Developer Studio for enhancing developer productivity and Acquia Digital Asset Manager for centralizing creative assets. The company's services aim to empower organizations to achieve impactful, contextually relevant digital experiences that enhance customer engagement.

Nuvaira

Series D in 2014
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

Transcend Medical

Series C in 2014
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

Intacct

Series G in 2014
Sage Intacct, Inc. is a cloud accounting software company that specializes in providing financial management solutions tailored for financial professionals. Its comprehensive platform includes applications for general ledger accounting, accounts payable, order management, accounts receivable, cash management, and financial reporting, among other functionalities. The company also supports a range of services such as contract and subscription billing, inventory management, project accounting, and vendor payment solutions. Sage Intacct serves a diverse clientele across various sectors, including accounting firms, healthcare, nonprofits, and wholesale distribution, primarily in the North American market. Established in 1999 and headquartered in San Jose, California, the company has expanded internationally with locations in India and Romania. Sage Intacct, formerly known as Intacct Corporation, operates as a subsidiary of The Sage Group plc and is recognized as a preferred provider by the AICPA, garnering high customer satisfaction ratings and multiple awards for its leadership and workplace culture.

Guardian Analytics

Series E in 2013
Guardian Analytics, Inc. is a company specializing in behavior-based fraud prevention solutions aimed at safeguarding online and mobile banking activities. Founded in 2005 and headquartered in Mountain View, California, the company provides a range of services tailored for enterprise banks, community banks, and credit unions. Its offerings include omni-channel fraud prevention, visual analytics, integrated risk databases, and cross-channel risk scoring. Additionally, Guardian Analytics features a managed service called FraudDESK, which minimizes staffing impact while enhancing fraud protection. The company's advanced platform utilizes behavioral analytics and machine learning to detect and prevent fraudulent activities across various banking channels, including digital banking and real-time transactions. Guardian Analytics serves over 400 financial institutions, helping them mitigate fraud risk, enhance customer trust, and improve operational efficiency while addressing compliance requirements.

InsideView

Series D in 2013
InsideView Technologies, Inc. specializes in developing Customer Relationship Management (CRM) solutions that enhance sales, marketing, and account management efforts. Founded in 2005 and based in San Francisco, the company provides a range of products designed to deliver comprehensive company and contact data, social insights, and business connections. Key offerings include InsideView Refresh, which focuses on data cleansing and management for Salesforce users; InsideView Data Integrity for customer data management; and InsideView Append, a lightning data application. The company's Targeting Intelligence platform enables sales and marketing teams to identify and engage with the best prospects, facilitating more relevant interactions and improved deal closures. InsideView's solutions are utilized by over 500,000 professionals across more than 20,000 leading companies, and it maintains partnerships with several major CRM providers, including Microsoft and Salesforce. Additionally, InsideView collaborates with various content providers to enhance its data offerings.

Vormetric

Venture Round in 2013
Vormetric is the leader in Enterprise Encryption and Key Management for corporations. Vormetric is growing 40% yr/yr. Vormetric is the only vendor that allows corporations to encrypt ALL DATABASE (all versions) and ALL files across the Enterprise. Vormetric's provide very tight access controls to ensure only authorized users and applications can have access to the data. Vormetric claims more than 1,100 customers, including 17 companies of the Fortune 25. Vormetric technology has received strong market validation for its innovative approach to data security, including selection by IBM as the only database encryption solution for DB2 and Informix on LinuxTM, Unix® and Windows; selection by Symantec to provide the Symantec Veritas NetBackupTM Media Server Encryption Option; partnership with Oracle to secure the execution environment for Oracle® Database Vault.

Colorescience

Series A in 2013
Colorescience, Inc. specializes in the production and sale of mineral-based cosmetics and sunscreen products. Founded in 2000 and based in Carlsbad, California, the company offers a range of treatment products aimed at addressing various skin concerns, including pigmentation, redness, dark circles, and signs of aging, as well as catering to different skin types such as sensitive, oily, and dry skin. Its product line includes UV protectors, primers, foundations, and enhancers, all designed with high-quality ingredients and formulations. Colorescience distinguishes itself in the luxury aesthetic makeup market by focusing on efficacy and ease of use. The company distributes its products through a network of licensed physicians, luxury spas, retailers, and online channels, emphasizing its commitment to reducing skin cancer and other skin conditions.

Nuvaira

Series C in 2013
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

Janrain

Series C in 2013
Janrain, Inc. specializes in customer identity and access management (CIAM) solutions, offering the Janrain Identity Cloud, which is designed for real-time identity management, security, and activation for global enterprises. Founded in 2002 and headquartered in Portland, Oregon, Janrain has expanded its presence with additional offices in cities including Redwood City, Austin, London, Paris, Kyiv, Guadalajara, São Paulo, Ningbo, and Bengaluru. The company serves a diverse range of sectors, including consumer brands, financial services, healthcare, and education, among others. Janrain is noted for its pioneering role in developing social login and for being a founding member of the OpenID Foundation, contributing significantly to digital authentication protocols used worldwide. As of early 2019, Janrain operates as a subsidiary of Akamai Technologies, Inc.

Nexxo Financial

Series F in 2013
Nexxo’s Everyday Financial Services Platform (EFS) enables businesses to offer consumers an integrated suite of financial services including check cashing, money transfer, bill pay, money orders, pre-paid card servicing and phone minute top-ups; all delivered in a common, easy-to-use interface via self-service kiosk, teller-assisted desktop, mobile, and web channels.

Intacct

Venture Round in 2012
Sage Intacct, Inc. is a cloud accounting software company that specializes in providing financial management solutions tailored for financial professionals. Its comprehensive platform includes applications for general ledger accounting, accounts payable, order management, accounts receivable, cash management, and financial reporting, among other functionalities. The company also supports a range of services such as contract and subscription billing, inventory management, project accounting, and vendor payment solutions. Sage Intacct serves a diverse clientele across various sectors, including accounting firms, healthcare, nonprofits, and wholesale distribution, primarily in the North American market. Established in 1999 and headquartered in San Jose, California, the company has expanded internationally with locations in India and Romania. Sage Intacct, formerly known as Intacct Corporation, operates as a subsidiary of The Sage Group plc and is recognized as a preferred provider by the AICPA, garnering high customer satisfaction ratings and multiple awards for its leadership and workplace culture.

Nuvaira

Series B in 2012
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

ForSight VISION5

Venture Round in 2012
ForSight VISION5 was founded in 2010 as the fifth company created by the ophthalmic product incubator, ForSight Labs. ForSight VISION5 is developing non-invasive products that replace eye drops and provide sustained therapy for major eye diseases including glaucoma, dry eye, and allergy. The company is currently in its second Phase 2 clinical study for its lead product, the Helios insert.

Histogenics

Series C in 2012
Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Our regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Our first investigational product candidate, NeoCart®, leverages our platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.

Zyga Technology

Series C in 2012
Zyga Technology is a surgical solutions provider developing & commercializing medical devices for treating spine problems. In addition to the SImmetry Sacroiliac Joint Fusion System, the company is also developing the Glyder Facet Restoration Device. Zyga has put together a team of engineers, marketing personnel, and management with significant experience developing medical devices for the spine industry. Zyga Technology was founded in 2008 and is headquartered in Minnesota, USA.

DFine

Venture Round in 2012
DFINE Inc. develops minimally invasive therapeutic devices that are used to treat pathologies of the vertebrae, metastatic spinal tumors, and vertebral compression fractures. It offers STAR, a tumor ablation system for palliative treatment in spinal procedures by ablation of metastatic malignant lesions in a vertebral body; vertebral augmentation systems for percutaneous delivery of bone cement and the treatment of pathological fractures; and vertebroplasty systems. The company was founded in 2004 and is based in San Jose, California. As of July 6, 2016, DFINE Inc. operates as a subsidiary of Merit Medical Systems, Inc..

Cayenne Medical

Venture Round in 2012
Cayenne Medical, Inc. a sports medicine company, provides arthroscopic surgery products. It offers AperFix System that enables the surgeons to perform anterior cruciate ligament (ACL) reconstruction using the hamstring and various soft tissue grafts. The company also provides AperFix Femoral device to restore native knee kinematics; AperFix Tibial device for anatomic reconstruction applications; and iFix Interference Screw System for ACL reconstruction procedure using the bone-patellar tendon-bone and various bone-tendon-bone grafts. In addition, it offers interference screws and shoulder products. Cayenne Medical, Inc. was founded in 2005 and is based in Scottsdale, Arizona.

BlueKai

Series D in 2012
BlueKai is a leading data management platform that provides an enterprise solution for managing and activating first, second, and third-party data to enhance marketing effectiveness. It offers a comprehensive system designed for marketers and publishers to optimize their cross-channel marketing strategies, enabling them to unlock reach, scale, and efficiency through data utilization. As a pioneer in the data-driven marketing sector, BlueKai features an advanced Data Management Platform and a well-connected Data Exchange. The company serves thousands of clients and is trusted by numerous Fortune 30 brands to activate their data, solidifying its position as a significant player in the marketing technology landscape. In recognition of its innovation and impact, BlueKai has received accolades such as being named to Forbes' "50 Most Promising US Companies" list and Fast Company's "10 Most Innovative Global Companies in Big Data."

Code42

Series A in 2012
Code42 Software, Inc. is an enterprise SaaS provider specializing in cloud endpoint data protection and security solutions for businesses and educational institutions. The company offers several key products, including Code42 CrashPlan, which provides continuous backup of distributed end-user data, and Code42 Next-Gen DLP, a data loss protection solution designed for resource-constrained security and IT teams. Additionally, Code42's Incydr solution safeguards intellectual property, source code, and trade secrets while enabling compliance with regulatory requirements. Founded in 2001 and headquartered in Minneapolis, Minnesota, Code42 has built a reputation for helping over 50,000 organizations globally protect their data without compromising collaboration among employees. The company also has a strategic partnership with Exabeam and maintains a presence in Amersham, United Kingdom.

Transcend Medical

Series B in 2012
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

DFine

Venture Round in 2011
DFINE Inc. develops minimally invasive therapeutic devices that are used to treat pathologies of the vertebrae, metastatic spinal tumors, and vertebral compression fractures. It offers STAR, a tumor ablation system for palliative treatment in spinal procedures by ablation of metastatic malignant lesions in a vertebral body; vertebral augmentation systems for percutaneous delivery of bone cement and the treatment of pathological fractures; and vertebroplasty systems. The company was founded in 2004 and is based in San Jose, California. As of July 6, 2016, DFINE Inc. operates as a subsidiary of Merit Medical Systems, Inc..

BlackDuck

Series E in 2011
Black Duck secures and manages open source software worldwide, eliminating open source security vulnerabilities and license compliance pain. With the rapid, widespread adoption of open-source software, Black Duck is a key component of Synopsys’ Software Integrity Platform, the most comprehensive solution for integrating security into the SDLC and software supply chain. Black Duck was established in 2002 and is based in Burlington, Massachusetts, United States.

RF Surgical Systems

Venture Round in 2011
RF Surgical Systems, Inc. is the market leader in the detection and prevention of retained surgical sponges. The RF Surgical Detection System is the preferred solution in more than 1,500 operating rooms, trauma and labor and delivery suites nationwide. Since January 2011, more than 70 hospitals and surgical centers have joined the fast-growing list of care providers using RF Surgical Technology. RF Surgical Systems is based in Bellevue, Washington with R & D facilities in San Diego, California. The advanced technologies used in the RF Surgical Detection System are protected by U.S. patents. Regulatory clearance to market the system was granted by the U.S. Food and Drug Administration in November 2006.

Entellus Medical

Series E in 2011
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.

Guardian Analytics

Series D in 2011
Guardian Analytics, Inc. is a company specializing in behavior-based fraud prevention solutions aimed at safeguarding online and mobile banking activities. Founded in 2005 and headquartered in Mountain View, California, the company provides a range of services tailored for enterprise banks, community banks, and credit unions. Its offerings include omni-channel fraud prevention, visual analytics, integrated risk databases, and cross-channel risk scoring. Additionally, Guardian Analytics features a managed service called FraudDESK, which minimizes staffing impact while enhancing fraud protection. The company's advanced platform utilizes behavioral analytics and machine learning to detect and prevent fraudulent activities across various banking channels, including digital banking and real-time transactions. Guardian Analytics serves over 400 financial institutions, helping them mitigate fraud risk, enhance customer trust, and improve operational efficiency while addressing compliance requirements.

Transcend Medical

Series B in 2011
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

Intacct

Venture Round in 2011
Sage Intacct, Inc. is a cloud accounting software company that specializes in providing financial management solutions tailored for financial professionals. Its comprehensive platform includes applications for general ledger accounting, accounts payable, order management, accounts receivable, cash management, and financial reporting, among other functionalities. The company also supports a range of services such as contract and subscription billing, inventory management, project accounting, and vendor payment solutions. Sage Intacct serves a diverse clientele across various sectors, including accounting firms, healthcare, nonprofits, and wholesale distribution, primarily in the North American market. Established in 1999 and headquartered in San Jose, California, the company has expanded internationally with locations in India and Romania. Sage Intacct, formerly known as Intacct Corporation, operates as a subsidiary of The Sage Group plc and is recognized as a preferred provider by the AICPA, garnering high customer satisfaction ratings and multiple awards for its leadership and workplace culture.

8thBridge

Series B in 2011
8thBridge, headquartered in Minneapolis, Minnesota, is a Social Discovery platform that assists brands in enhancing product discovery and customer understanding. Founded in 2008, the company empowers brands to leverage social media for crowd-sourced content creation and deeper engagement with consumers. By focusing on the evolving dynamics between consumers and institutions, 8thBridge provides tools that enable retailers to gain valuable insights into customer behavior and preferences. The platform aims to convert social media interactions into measurable sales growth, addressing the challenges faced by marketing and e-commerce executives in monetizing their online presence. 8thBridge has collaborated with notable brands, including Ticketmaster and Delta Air Lines, and has been recognized as one of the top private companies in the world. It was acquired by Fluid, Inc. in April 2014 and is supported by investors such as Split Rock Partners and Trident Capital.

Sonoma Orthopedics

Series D in 2011
Sonoma Orthopedic Products designs, develops, and delivers proprietary orthopedic implants for physicians to address problematic fractures. The WaviBodyâ„¢ technology platform allows for quick, minimally invasive surgical solutions for active patients. Direct to Bone...Back To Life.

EBR Systems

Series D in 2011
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

FamilyFinds

Series A in 2010
FamilyFinds is an online daily promotions site exclusively focused on services and experiences for families, allowing customers to save up to 90% on family-friendly activities, restaurants and services. Currently they offer exclusive deals in Los Angeles and Chicago, with support for more cities on the way. By offering daily deals from hidden gems to popular places, FamilyFinds allows consumers to discover new places to visit, ideas for local family adventures and other value-added content that takes them from deal to experience. Through its members-only daily email, the company shares deals on hand-picked local merchants and insider info on unique family experiences in specific, hyper local communities.

Nuvaira

Series A in 2010
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

DFine

Venture Round in 2010
DFINE Inc. develops minimally invasive therapeutic devices that are used to treat pathologies of the vertebrae, metastatic spinal tumors, and vertebral compression fractures. It offers STAR, a tumor ablation system for palliative treatment in spinal procedures by ablation of metastatic malignant lesions in a vertebral body; vertebral augmentation systems for percutaneous delivery of bone cement and the treatment of pathological fractures; and vertebroplasty systems. The company was founded in 2004 and is based in San Jose, California. As of July 6, 2016, DFINE Inc. operates as a subsidiary of Merit Medical Systems, Inc..

8thBridge

Series A in 2010
8thBridge, headquartered in Minneapolis, Minnesota, is a Social Discovery platform that assists brands in enhancing product discovery and customer understanding. Founded in 2008, the company empowers brands to leverage social media for crowd-sourced content creation and deeper engagement with consumers. By focusing on the evolving dynamics between consumers and institutions, 8thBridge provides tools that enable retailers to gain valuable insights into customer behavior and preferences. The platform aims to convert social media interactions into measurable sales growth, addressing the challenges faced by marketing and e-commerce executives in monetizing their online presence. 8thBridge has collaborated with notable brands, including Ticketmaster and Delta Air Lines, and has been recognized as one of the top private companies in the world. It was acquired by Fluid, Inc. in April 2014 and is supported by investors such as Split Rock Partners and Trident Capital.

Twelve

Series A in 2010
Twelve manufactures medical devices. It was formerly known as Foundry Newco XII, Inc. The company was incorporated in 2009 and is based in Menlo Park, California.

Amcom Software

Private Equity Round in 2010
Amcom Software specializes in providing communication solutions designed for organizations that require efficient and reliable management of critical communications. Their offerings include advanced software for call center communications, emergency management, wireless messaging middleware, and paging infrastructure. These solutions cater to a diverse range of sectors, including healthcare, hospitality, education, business, industrial, and government. Amcom Software’s products enhance productivity and accuracy in mission-critical situations by offering features such as PC-based attendant consoles, call center recording and quality management, call accounting and reporting, and speech recognition. The company’s software is utilized by numerous leading organizations to streamline their communication processes effectively.

EBR Systems

Venture Round in 2009
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Entellus Medical

Series D in 2009
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.

Caring.com

Series B in 2009
Caring, LLC operates an online platform designed to assist family caregivers who are seeking information and support for aging loved ones. Founded in 2007 and based in San Mateo, California, the company provides a comprehensive Senior Care Directory that includes assisted living facilities, memory care communities, in-home care agencies, independent living communities, nursing homes, and hospice care centers. With nearly 55,000 consumer ratings and reviews, Caring.com aims to empower caregivers by offering valuable resources, including caregiving content, online support groups, and a toll-free referral line. The company addresses the challenges faced by the over 40 million caregivers in the United States, many of whom have little prior experience in caregiving, by helping them make informed decisions while saving time and money. The team at Caring.com consists of seasoned professionals with extensive experience in health and family media, many of whom are also caregivers themselves.

eBureau

Series C in 2009
eBureau was founded in 2004 and has become an industry leading provider of predictive analytics and information solutions. eBureau utilizes its patented technologies and big data assets to help businesses acquire customers, manage risks and maintain customer relationships. Our services access vast amounts of predictive data to deliver instant insights that help make critical decisions throughout the customer lifecycle and are helping Business-to-Consumer (B2C) and Business-to-Business (B2B) companies improve profitability, boost efficiencies, reduce losses and increase revenue. eBureau was founded to help companies make better informed, data-driven decisions about customers each and every day. eBureau helps companies understand: which prospects are more likely to become customers, which customers are likely to pay their bills on time, when there are elevated fraud risks and how to most efficiently collect past due bills. eBureau’s patented technology analyzes vast amounts of predictive data to help you with critical decisions throughout the customer lifecycle. eBureau offers several ready-to-use solutions and has the flexibility to customize a solution to your specific needs within the following areas: Marketing & Lead Management, Fraud Prevention, Credit Risk Assessment and Collections & Recovery.

Xora, Inc.

Venture Round in 2009
Xora is a global leader in mobile business applications. Our flagship solution is a suite of configurable cloud-based apps that help mobile businesses and their field employees work faster and smarter. Our apps turn any mobile device into powerful productivity and data collection tools. Our management application processes and reports data that can be used to make decisions that improve field operations. All of our solutions can be integrated with back-office systems and other applications to automate business processes and eliminate manual paperwork. More than 16,000 organizations rely on Xora every day to save money and grow their businesses. For more information, visit us at http://www.xora.com.

Nexis Vision

Series B in 2009
Nexis Vision develops ophthalmic solutions. The company is developing ocular surface technology for ophthalmic devices. The company was founded in 2007 and is based in Menlo Park, California. Nexis Vision, Inc. operates as a subsidiary of ForSight Labs, LLC.

Transcend Medical

Series B in 2009
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

Anulex Technologies

Series D in 2009
Anulex Technologies focus on developing proprietary medical technology to repair and seal the soft tissue of the spine (anulus) for patients undergoing a surgical procedure to remove a herniated disc (discectomy).

Atritech

Venture Round in 2009
Atritech is a private company located in Minneapolis, Minnesota. The company was founded in 2000 and has developed proprietary technology focused on replacing long term anticoagulation therapy for patients with non-valvular atrial fibrillation at risk of stroke. The first implants of the WATCHMAN® Left Atrial Appendage Closure Technology were performed in Germany in August of 2002 and in the United States in October of 2003. Since then the company has conducted a large randomized clinical trial comparing the WATCHMAN® Left Atrial Appendage Closure Technology to long term Warfarin therapy in patients with non-valvular atrial fibrillation at risk of stroke. The WATCHMAN® Device is CE Marked and available in many markets outside the United States. The WATCHMAN® Device is currently available For Investigational Use Only in the United States.

EBR Systems

Series C in 2008
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Entellus Medical

Series C in 2008
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.

Nexxo Financial

Series D in 2008
Nexxo’s Everyday Financial Services Platform (EFS) enables businesses to offer consumers an integrated suite of financial services including check cashing, money transfer, bill pay, money orders, pre-paid card servicing and phone minute top-ups; all delivered in a common, easy-to-use interface via self-service kiosk, teller-assisted desktop, mobile, and web channels.

Miramar Labs

Series B in 2008
Miramar Labs develops medical devices for aesthetic indications that treat primary axillary (underarm) hyperhidrosis in adults. The miraDry System cannot be used to treat hyperhidrosis elsewhere on the body, including the hands and feet. It was founded in 2006 and is based in Sunnyvale, California.

Cayenne Medical

Series C in 2008
Cayenne Medical, Inc. a sports medicine company, provides arthroscopic surgery products. It offers AperFix System that enables the surgeons to perform anterior cruciate ligament (ACL) reconstruction using the hamstring and various soft tissue grafts. The company also provides AperFix Femoral device to restore native knee kinematics; AperFix Tibial device for anatomic reconstruction applications; and iFix Interference Screw System for ACL reconstruction procedure using the bone-patellar tendon-bone and various bone-tendon-bone grafts. In addition, it offers interference screws and shoulder products. Cayenne Medical, Inc. was founded in 2005 and is based in Scottsdale, Arizona.

Nexis Vision

Series A in 2008
Nexis Vision develops ophthalmic solutions. The company is developing ocular surface technology for ophthalmic devices. The company was founded in 2007 and is based in Menlo Park, California. Nexis Vision, Inc. operates as a subsidiary of ForSight Labs, LLC.

Kspine

Series A in 2008
Kspine was developing implantable medical devices for the treatment of spine disorders.

Calabrio

Series B in 2007
Calabrio, Inc. is a customer experience intelligence company that specializes in developing and marketing workforce optimization software solutions for call centers. Its flagship product, Calabrio ONE, is an integrated software suite that includes modules for call recording, quality management, workforce management, and analytics, designed to enhance agent performance and customer insights. The company serves a diverse range of industries, including healthcare, telecommunications, retail, and finance, with over 4,000 clients worldwide. In addition to its software offerings, Calabrio provides professional services such as project management, training, and technical support. Founded in 2007 and headquartered in Minneapolis, Minnesota, Calabrio also has locations in Canada, the United Kingdom, Singapore, and Sweden. The company has been recognized as a leader in its field and is affiliated with notable industry programs, positioning it as a key player in optimizing customer experience through innovative technology.

Evalve

Series D in 2007
Evalve, Inc. engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves. It provides a non-surgical mitral valve repair system consisting of a steerable guide catheter, a clip delivery system, and an implant device that is used by interventional cardiologists to reduce mitral regurgitation. The company was incorporated in 1999 and is based in Menlo Park, California.

Atritech

Series D in 2007
Atritech is a private company located in Minneapolis, Minnesota. The company was founded in 2000 and has developed proprietary technology focused on replacing long term anticoagulation therapy for patients with non-valvular atrial fibrillation at risk of stroke. The first implants of the WATCHMAN® Left Atrial Appendage Closure Technology were performed in Germany in August of 2002 and in the United States in October of 2003. Since then the company has conducted a large randomized clinical trial comparing the WATCHMAN® Left Atrial Appendage Closure Technology to long term Warfarin therapy in patients with non-valvular atrial fibrillation at risk of stroke. The WATCHMAN® Device is CE Marked and available in many markets outside the United States. The WATCHMAN® Device is currently available For Investigational Use Only in the United States.

Caring.com

Series A in 2007
Caring, LLC operates an online platform designed to assist family caregivers who are seeking information and support for aging loved ones. Founded in 2007 and based in San Mateo, California, the company provides a comprehensive Senior Care Directory that includes assisted living facilities, memory care communities, in-home care agencies, independent living communities, nursing homes, and hospice care centers. With nearly 55,000 consumer ratings and reviews, Caring.com aims to empower caregivers by offering valuable resources, including caregiving content, online support groups, and a toll-free referral line. The company addresses the challenges faced by the over 40 million caregivers in the United States, many of whom have little prior experience in caregiving, by helping them make informed decisions while saving time and money. The team at Caring.com consists of seasoned professionals with extensive experience in health and family media, many of whom are also caregivers themselves.

Mirabilis Medical

Series A in 2007
Mirabilis Medical, Inc. is a medical device company based in Bothell, Washington, that specializes in the development and manufacture of ultrasound devices aimed at the non-invasive treatment of uterine fibroids, a common condition affecting women. Established in 2004, the company provides innovative solutions for gynecologists, utilizing high-resolution ultrasound imaging to accurately locate and treat fibroid tissue deep within the body without the need for incisions or punctures. This proprietary technology allows for effective ablation of pathological tissue while minimizing damage to surrounding areas, positioning Mirabilis Medical as a key player in the field of gynecological treatments.

eBureau

Series B in 2007
eBureau was founded in 2004 and has become an industry leading provider of predictive analytics and information solutions. eBureau utilizes its patented technologies and big data assets to help businesses acquire customers, manage risks and maintain customer relationships. Our services access vast amounts of predictive data to deliver instant insights that help make critical decisions throughout the customer lifecycle and are helping Business-to-Consumer (B2C) and Business-to-Business (B2B) companies improve profitability, boost efficiencies, reduce losses and increase revenue. eBureau was founded to help companies make better informed, data-driven decisions about customers each and every day. eBureau helps companies understand: which prospects are more likely to become customers, which customers are likely to pay their bills on time, when there are elevated fraud risks and how to most efficiently collect past due bills. eBureau’s patented technology analyzes vast amounts of predictive data to help you with critical decisions throughout the customer lifecycle. eBureau offers several ready-to-use solutions and has the flexibility to customize a solution to your specific needs within the following areas: Marketing & Lead Management, Fraud Prevention, Credit Risk Assessment and Collections & Recovery.

Compete

Series C in 2007
Compete specializes in providing digital intelligence services that assist brands in enhancing their marketing strategies by analyzing online consumer behavior. The company offers a range of services that include consumer behavior data for competitive research, performance benchmarking, identification of effective keywords, and analysis of referral sources. It enables businesses to gain insights into online market shares, discover competitors' traffic sources, and pinpoint opportunities to enhance website engagement and conversion metrics. Additionally, Compete provides tools for measuring referral partners, creating connections between online and offline efforts, and identifying cross-selling and up-selling opportunities. The company also focuses on mobile behavioral intelligence to understand the impact of mobile devices on consumer shopping habits. Through these services, Compete aims to deliver actionable insights and comprehensive reports that support informed decision-making for brands seeking to improve customer loyalty and reduce operational costs.

CareParent

Series A in 2007
CareParent Inc. provides online services which include elder care information and resources. The company is based in Palo Alto, California.

Entellus Medical

Series B in 2007
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.

ForSight Labs

Series A in 2007
ForSight Labs is focused on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. Our environment is creative and collaborative; a place where entrepreneurs and investors work together to drive innovative technologies through concept, development, and ultimately commercialization in high-impact eye care companies (ForSight VISION companies). Each day millions of people rely on their vision and suffer when it is lost. There are few disabilities as impactful to quality of life as the loss of vision. The number of people with impaired vision in the US, including blindness, is expected to more than double over the next three decades. Recent estimates of the cost of vision loss in the US exceed $50 billion dollars annually. ForSight Labs brings together highly motivated and capable team members, clinicians and investors focused on starting and sustaining efforts to deliver innovative solutions to the ophthalmic community and the patients it serves.

Gearworks

Venture Round in 2007
Gearworks provides location-based mobile business applications – in collaboration with wireless carriers – that enable customers to manage their mobile resources. Gearworks products operate under the etrace, Field Force Manager, appmosphere and OnCare brands

Cayenne Medical

Series B in 2007
Cayenne Medical, Inc. a sports medicine company, provides arthroscopic surgery products. It offers AperFix System that enables the surgeons to perform anterior cruciate ligament (ACL) reconstruction using the hamstring and various soft tissue grafts. The company also provides AperFix Femoral device to restore native knee kinematics; AperFix Tibial device for anatomic reconstruction applications; and iFix Interference Screw System for ACL reconstruction procedure using the bone-patellar tendon-bone and various bone-tendon-bone grafts. In addition, it offers interference screws and shoulder products. Cayenne Medical, Inc. was founded in 2005 and is based in Scottsdale, Arizona.

Transcend Medical

Series A in 2006
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

MyNewPlace

Series B in 2006
MyNewPlace is a prominent apartment listing website in the United States, facilitating connections between landlords and potential tenants. The platform offers a comprehensive search feature for apartments and homes for rent, along with valuable city information and demographic data. Users can access property details, including photos and videos, as well as integrated mapping to enhance their search experience. MyNewPlace is recognized for its user-friendly design and was a pioneer in incorporating social networking features into the rental process. The company also provides resources such as rental living tips through its blog, LocalTalk. Founded in San Francisco's SoMa neighborhood, MyNewPlace is owned by RealPage, headquartered in Carrollton, Texas. In 2009, the company expanded its offerings with a mobile app that includes GPS-based apartment searches and note-taking capabilities for listings.

Anulex Technologies

Series C in 2006
Anulex Technologies focus on developing proprietary medical technology to repair and seal the soft tissue of the spine (anulus) for patients undergoing a surgical procedure to remove a herniated disc (discectomy).

Entellus Medical

Series A in 2006
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.

Atritech

Series C in 2006
Atritech is a private company located in Minneapolis, Minnesota. The company was founded in 2000 and has developed proprietary technology focused on replacing long term anticoagulation therapy for patients with non-valvular atrial fibrillation at risk of stroke. The first implants of the WATCHMAN® Left Atrial Appendage Closure Technology were performed in Germany in August of 2002 and in the United States in October of 2003. Since then the company has conducted a large randomized clinical trial comparing the WATCHMAN® Left Atrial Appendage Closure Technology to long term Warfarin therapy in patients with non-valvular atrial fibrillation at risk of stroke. The WATCHMAN® Device is CE Marked and available in many markets outside the United States. The WATCHMAN® Device is currently available For Investigational Use Only in the United States.

eBureau

Series A in 2006
eBureau was founded in 2004 and has become an industry leading provider of predictive analytics and information solutions. eBureau utilizes its patented technologies and big data assets to help businesses acquire customers, manage risks and maintain customer relationships. Our services access vast amounts of predictive data to deliver instant insights that help make critical decisions throughout the customer lifecycle and are helping Business-to-Consumer (B2C) and Business-to-Business (B2B) companies improve profitability, boost efficiencies, reduce losses and increase revenue. eBureau was founded to help companies make better informed, data-driven decisions about customers each and every day. eBureau helps companies understand: which prospects are more likely to become customers, which customers are likely to pay their bills on time, when there are elevated fraud risks and how to most efficiently collect past due bills. eBureau’s patented technology analyzes vast amounts of predictive data to help you with critical decisions throughout the customer lifecycle. eBureau offers several ready-to-use solutions and has the flexibility to customize a solution to your specific needs within the following areas: Marketing & Lead Management, Fraud Prevention, Credit Risk Assessment and Collections & Recovery.

ForSight Labs

Venture Round in 2006
ForSight Labs is focused on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. Our environment is creative and collaborative; a place where entrepreneurs and investors work together to drive innovative technologies through concept, development, and ultimately commercialization in high-impact eye care companies (ForSight VISION companies). Each day millions of people rely on their vision and suffer when it is lost. There are few disabilities as impactful to quality of life as the loss of vision. The number of people with impaired vision in the US, including blindness, is expected to more than double over the next three decades. Recent estimates of the cost of vision loss in the US exceed $50 billion dollars annually. ForSight Labs brings together highly motivated and capable team members, clinicians and investors focused on starting and sustaining efforts to deliver innovative solutions to the ophthalmic community and the patients it serves.

BigFix

Series E in 2005
BigFix, Inc. provides an IT security and operations platform that enables real-time visibility and control of globally distributed desktop, mobile, and server computers. The company offers BigFix Platform that instruments a messaging and management nervous system, as well as distributes the work of managing IT infrastructures to managed devices; BigFix AntiThreat for endpoint security; BigFix IT Policy Enforcement to set and enforce security policies and processes; and BigFix Systems Management that focuses on automating IT operations tasks. It also provides BigFix Policy Content Modules to develop custom management content. In addition, the company offers products support, consumer edition support, and professional services. It serves companies, government agencies, and public sector institutions. The company was founded in 1997 and is based in Emeryville, California.

EBR Systems

Series B in 2005
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Vendavo

Series E in 2005
Vendavo is the provider of price management and optimization software for business-to-business companies worldwide. The Vendavo Enterprise Pricing Suite solves pricing problems by giving businesses true enterprise-wide control of their entire pricing process. Vendavo combines pricing science, pricing best practices, and enterprise-class software to drive improvements in average prices at every stage of the pricing process, from segmentation to deal close. Added up, these improvements deliver significant increases in profits from 10% to 30%. Vendavo is the enterprise price management and optimization solution of choice for some of the worlds biggest companies in chemicals, high-tech, industrial manufacturing, consumer products, mill products and distribution. SAP, the worlds leading provider of business software, with more than 33,200 customers in more than 120 countries, sources its price and margin management solution from Vendavo. It is sold by SAP worldwide under the name SAP Price and Margin Management.

Spanlink Communications

Series A in 2005
Spanlink Communications, Inc. provides business communications technology and network integration solutions in the United States and internationally. It offers packaged applications, such as Spanlink Courtesy Callback that improves customer satisfaction and agent utilization rates; Customer Survey Manager, which provides users with a solution for creating, launching, and managing automated customer feedback surveys; Spanlink Top Customer that enables users to give designated customers attention; and SolutionWatch, an enterprise-grade application monitoring and systems reporting tool to provide alerts on flaws in the voice and data network. The company also provides CentralControl, a system management product that provides the multi-tenancy to manage voice network, enables senior level control at the data center, and provides access for routine changes at the edge; and IVR toolkits for unified customer voice portal, unified contact center enterprise, and unified contact center express platforms. In addition, it offers analysis, design, implementation, validation, launch, transition, and support services; consultative and assessment services, such as solution value analysis, voice readiness assessment, recording studio, reporting assessment, simulation testing, and post-deployment assessment services; and planning, migration, and support services. Further, Spanlink Communications provides contact center solutions, such as unified communications, unified customer contact, and network systems solutions; and interactive intelligence solutions, including enterprise IP telephony, contact center, hosted and on-premise contact center, and business process automation solutions. The company integrates unified communications, customer interaction, workforce optimization, and system management products that exploit the benefits of VoIP network infrastructures. Spanlink Communications, Inc. was founded in 1988 and is based in Minneapolis, Minnesota.

Cierra

Funding Round in 2005
Cierra is a medical device company focused on the invasive treatment of heart conditions. The company was founded in 2003 and is based in Redwood City, California.